Document is current
Any future updates will be listed below
-
Authors
Ziadeh, Hachem
Calaway, Adam
Gupta, Sanjay
Bodner, Donald
Brown, Jason R.
Schumacher, Fredrick R.
Wu, Chen-Han Wilfred
-
Funding
Funding for this research was provided by:
National Institutes of Health (DK135933)
- License Information
-
More Information
Article History
Received: 22 March 2025
Accepted: 22 April 2025
First Online: 7 May 2025
Declarations
:
: Adam Calaway: Key Opinion Leader at Fortec Medical; Received support for attending meetings and/or travel to ASCO GU 2024 from ASCO.—Sanjay Gupta: Received support for attending meetings and/or travel from Cancers-MDPI journal.—Jason Brown: Speakers’ Bureau at EMD Serono; Travel support from Janssen; Scientific Advisory Board at EMD Serono, Janssen, and Pfizer.—Chen-Han Wilfred Wu is a member of the Executive Committee for the Harrington Scholar-Innovator Award Program, and conducts clinical trials with ModernaTx, Inc.
: The UK Biobank study was approved by the National Health Service (NHS) Northwest Centre for Research Ethics Committee (Ref: 11/NW/0382). Our research has been conducted using the UK Biobank resource under application number 87480.
